CN1399971A - Biological preparation for treating burn and preparation method thereof - Google Patents
Biological preparation for treating burn and preparation method thereof Download PDFInfo
- Publication number
- CN1399971A CN1399971A CN01123583A CN01123583A CN1399971A CN 1399971 A CN1399971 A CN 1399971A CN 01123583 A CN01123583 A CN 01123583A CN 01123583 A CN01123583 A CN 01123583A CN 1399971 A CN1399971 A CN 1399971A
- Authority
- CN
- China
- Prior art keywords
- preparation
- biological preparation
- burn
- powder
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 66
- 238000000855 fermentation Methods 0.000 claims abstract description 10
- 230000004151 fermentation Effects 0.000 claims abstract description 10
- 239000000843 powder Substances 0.000 claims description 32
- 239000007788 liquid Substances 0.000 claims description 19
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 15
- 239000001963 growth medium Substances 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 10
- 238000003756 stirring Methods 0.000 claims description 10
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 8
- 238000006243 chemical reaction Methods 0.000 claims description 8
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 7
- 239000012798 spherical particle Substances 0.000 claims description 7
- 241000589220 Acetobacter Species 0.000 claims description 6
- 244000046101 Sophora japonica Species 0.000 claims description 6
- 235000010586 Sophora japonica Nutrition 0.000 claims description 6
- 241000628997 Flos Species 0.000 claims description 5
- IRXRGVFLQOSHOH-UHFFFAOYSA-L dipotassium;oxalate Chemical compound [K+].[K+].[O-]C(=O)C([O-])=O IRXRGVFLQOSHOH-UHFFFAOYSA-L 0.000 claims description 5
- 230000001954 sterilising effect Effects 0.000 claims description 5
- 238000004659 sterilization and disinfection Methods 0.000 claims description 5
- 244000068988 Glycine max Species 0.000 claims description 4
- 235000010469 Glycine max Nutrition 0.000 claims description 4
- 238000004458 analytical method Methods 0.000 claims description 4
- 210000000582 semen Anatomy 0.000 claims description 4
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 4
- 230000015572 biosynthetic process Effects 0.000 claims description 3
- 208000027418 Wounds and injury Diseases 0.000 abstract description 40
- 206010052428 Wound Diseases 0.000 abstract description 39
- 230000000694 effects Effects 0.000 abstract description 11
- 208000015181 infectious disease Diseases 0.000 abstract description 9
- 210000001519 tissue Anatomy 0.000 abstract description 8
- 206010053615 Thermal burn Diseases 0.000 abstract description 7
- 230000035876 healing Effects 0.000 abstract description 7
- 231100000241 scar Toxicity 0.000 abstract description 6
- 238000004519 manufacturing process Methods 0.000 abstract description 5
- 230000012010 growth Effects 0.000 abstract description 4
- 241000193755 Bacillus cereus Species 0.000 abstract description 2
- 206010063560 Excessive granulation tissue Diseases 0.000 abstract description 2
- 238000009825 accumulation Methods 0.000 abstract description 2
- 210000001126 granulation tissue Anatomy 0.000 abstract description 2
- 230000017074 necrotic cell death Effects 0.000 abstract description 2
- 206010028851 Necrosis Diseases 0.000 abstract 1
- 230000007794 irritation Effects 0.000 abstract 1
- 230000000750 progressive effect Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 description 29
- 238000000034 method Methods 0.000 description 28
- 229940079593 drug Drugs 0.000 description 18
- 244000005700 microbiome Species 0.000 description 12
- 238000011084 recovery Methods 0.000 description 11
- 241000894006 Bacteria Species 0.000 description 10
- 241001465754 Metazoa Species 0.000 description 9
- 239000002253 acid Substances 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 210000000589 cicatrix Anatomy 0.000 description 8
- 206010039509 Scab Diseases 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 238000004321 preservation Methods 0.000 description 6
- 239000007921 spray Substances 0.000 description 6
- 241000699670 Mus sp. Species 0.000 description 5
- 238000004140 cleaning Methods 0.000 description 5
- 239000008187 granular material Substances 0.000 description 5
- 208000032544 Cicatrix Diseases 0.000 description 4
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- 206010039580 Scar Diseases 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 235000011121 sodium hydroxide Nutrition 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 3
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 3
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 3
- 238000005842 biochemical reaction Methods 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 210000001217 buttock Anatomy 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 238000001804 debridement Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 210000003414 extremity Anatomy 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 230000008733 trauma Effects 0.000 description 3
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 241000222122 Candida albicans Species 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 229910000831 Steel Inorganic materials 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 238000001266 bandaging Methods 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000005018 casein Substances 0.000 description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
- 235000021240 caseins Nutrition 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 238000010891 electric arc Methods 0.000 description 2
- 238000011010 flushing procedure Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- 150000004032 porphyrins Chemical class 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 210000004706 scrotum Anatomy 0.000 description 2
- 206010040882 skin lesion Diseases 0.000 description 2
- 231100000444 skin lesion Toxicity 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 239000010959 steel Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 208000031648 Body Weight Changes Diseases 0.000 description 1
- 206010007134 Candida infections Diseases 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 208000009043 Chemical Burns Diseases 0.000 description 1
- 208000018380 Chemical injury Diseases 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 206010014568 Empyema Diseases 0.000 description 1
- 241000194032 Enterococcus faecalis Species 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 244000166124 Eucalyptus globulus Species 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 241001299553 Ilex chinensis Species 0.000 description 1
- 241001100935 Ilex purpurea Species 0.000 description 1
- 235000003366 Ilex purpurea Nutrition 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- TYMRLRRVMHJFTF-UHFFFAOYSA-N Mafenide Chemical compound NCC1=CC=C(S(N)(=O)=O)C=C1 TYMRLRRVMHJFTF-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- GIAZPLMMQOERPN-YUMQZZPRSA-N Val-Pro Chemical compound CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(O)=O GIAZPLMMQOERPN-YUMQZZPRSA-N 0.000 description 1
- 206010048038 Wound infection Diseases 0.000 description 1
- RSWGJHLUYNHPMX-ONCXSQPRSA-N abietic acid Chemical compound C([C@@H]12)CC(C(C)C)=CC1=CC[C@@H]1[C@]2(C)CCC[C@@]1(C)C(O)=O RSWGJHLUYNHPMX-ONCXSQPRSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 229960005475 antiinfective agent Drugs 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000004579 body weight change Effects 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 201000003984 candidiasis Diseases 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 230000035617 depilation Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 208000018685 gastrointestinal system disease Diseases 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 239000003721 gunpowder Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000003118 histopathologic effect Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000001524 infective effect Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 229960003640 mafenide Drugs 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 238000009629 microbiological culture Methods 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 230000005622 photoelectricity Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000001117 sulphuric acid Substances 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000008467 tissue growth Effects 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 210000001364 upper extremity Anatomy 0.000 description 1
- 230000009278 visceral effect Effects 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 238000005491 wire drawing Methods 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a biological preparation for treating burn and a method for producing the preparation, wherein the preparation contains bacillus cereus CGMCC0601 fermentation liquor. The biological preparation has good curative effects on pain, exudation, infection, deep accumulation, progressive necrosis of burn tissues and scar healing of deep II-degree wounds, can dry the surface of a scald, reduce exudation, accelerate the growth of new granulation tissues and promote the healing of the scald tissues by using the biological preparation, and has the advantages of small irritation, quick pain relieving, effective infection control, short treatment course, no scar and the like.
Description
The present invention relates to medicinal preparation and preparation method thereof, specifically belong to the biological preparation of treatment burn and the method for producing said preparation.
Burn is a kind of commonly encountered diseases, frequently-occurring disease, also is the higher trauma of disability rate.Show that according to the area sampling investigation annual burn crowd's sickness rate is 2% person-time, remained scar ratio is about 30%.The normal method that adopts of clinical treatment burn generally is after carrying out the wound surface early time treatment at present, or adopts occlusive dressing or adopt exposure method to treat (" burn treating " Li Ao chief editor, the People's Health Publisher publishes).Occlusive dressing is the thick dressing wrapping wound surface with the sterilization suction, makes it to be isolated from the outside, with the protection wound surface.The weak point of this method is, when wrapping is handled, the dressing of wrapping internal layer usually occur or with wound surface adhesion, exchange difficulty, or drainage effect is not good enough.In the bandaging method for treating process, also usually because the wound surface humidity is brought out infection.Exposure method is that burn wound is exposed in the dry air, covers or wrapping without dressing, makes the sepage of wound surface and slough be dried to crust, with the temporary protection wound surface.Though this method wound surface is unfavorable for the growth of antibacterial, can make the district's tissue that is retarded by silt withered downright bad, its damaged condition is not second to the damage of initial stage burn.Exposure method requires high to external environment condition, and the dry crusts time is long, generally can become crust at burn after 48 hours.Prior treatment method is fit to the medicine that burned skin uses because of lacking, thereby curative effect is not fully up to expectations.In addition, no matter be occlusive dressing or exposure method, during debridement, all to carry out the wound surface infection and handle in early days.The selected anti-infectives of debridement mainly contains three classes: the one, and Chinese herbal and crude drugs preparations is as Ilex purpurea Hassk.[I.chinensis Sims, Radix Ilicis Pubescentis, Rhizoma Coptidis, Cortex Phellodendri, eucalyptus leaves etc.; The 2nd, the chemicals preparation is as hydrogen peroxide, bromo geramine, mafenide etc.; The 3rd, antibiotic formulations such as penicillin, gentamycin etc.Because most drug all can absorb from wound surface, so large tracts of land uses these medicines, and especially concentration is excessive or usually can cause when using powder and poison or visceral lesion.Moreover these medicines generally all have certain zest, usually can increase misery to the patient in use.
Purpose of the present invention just provides a kind of suitable burned skin healing, little, the eutherapeutic biological preparation of zest, and a kind of method for preparing said preparation is provided simultaneously.
The object of the present invention is achieved like this, and prepared biological preparation contains Bacillus cercus CGMCC0601 fermentation liquid.
The microorganism L-72 (being microorganism used therefor of the present invention) that Bacillus cercus CGMCC0601 fermentation liquid is used, through Institute of Microorganism, Academia Sinica (foundation 1, Krieg N.R.et al.Bergey ' s Manual ofSystematic Bacteriology (Vol, 2) p.1105-1138.1986.2, Colin RHarwood, Bacillus, Plenum Press, 1989.3, " bacillus " Cai Miaoying etc. such as RE Gordon translates agriculture publishing house 1978.) be accredited as Bacillus cercus (Bacillus cereus).Microorganism used therefor of the present invention has been submitted China Microbial Culture Preservation Commission's common micro-organisms center preservation in the present patent application a few days ago, and preserving number is CGMCC0601, and preservation day is July 12 calendar year 2001.
It is shaft-like that microorganism used therefor of the present invention is Gram-positive, and size is 0.9-1.0 * 2.5-4.0 μ; Spore is oval, and near-end is given birth to, and does not expand; The particulate accumulation of poly-(PHB) is arranged in the born of the same parents; Catalase and oxidase are all positive, and the anaerobe growth is positive, and the V-P reacting positive produces acid to glucose, arabinose, xylose, mannitol are not produced acid, hydrolyzed starch, decomposing casein utilizes citrate and propionate, V-P reacts end of a period, and pH value is 5.0, does not grow in 7%NaCl.
Microorganism used therefor growth conditions of the present invention: aerobic environment, pH value 7.8-8.5; Temperature 28-32 ℃; Cultivation conditions: leave standstill, dynamically all can; Production cycle: left standstill dynamically 10-16 hour 60-72 hour.
Microorganism used therefor of the present invention has good stable.This microorganism is found in 1972, reserves seed for planting because of mycete there being stronger inhibitory action separate, and 4 ℃ of preservations are standby.Every through two months voltage regulator tube (going down to posterity) once; Each to screening in 2 years once, choosing colony is big, thickness, stretched filament, neat in edge, Jing Xiaguan are looked into the special pattern structure that this bacterium is arranged, and can choose, amplification culture is decided to be female the kind, is used for preparation.
The Physiology and biochemistry of doing in per 5 years once than system detects (seeing Table 1), uses through the cultivation of two more than ten years, does not find that this bacterium has variation phenomenon, the preparation that annual different times is produced, and drug effect is zero difference also.
This microorganism is difficult for producing variation phenomenon in use, preservation and the process that repeatedly goes down to posterity, and pretending is that a production strain is reliable and promising.
This microorganism had for two more than ten years from finding so far, always went down to posterity more than 100 time, in biochemical reactions and use, found no variation and decay.Its main biochemical reactions detects and sees Table 1.
Table 1: Bacillus cercus CGMCC0601 major physiological biochemical reaction detects table
Test item detection time (year, month)
72.5?77.5?82.8?88.5?93.7
Gram+++++
Bacterium colony thickness stretched filament+++++
The special decorative pattern of bacterium colony+++++
Liquid culture formation Mycoderma+++++
Amylase+++++
Casein+++++
Nitrate+++++
Acetate+++++
The V-P reaction+++++
The 7.5%NaCI growth-----
Anaerobic growth-----
The acid of glucose product+++++
The acid of lactose product-----
The acid of sucrose product+++++
The acid of maltose product+++++
The acid of mannitol product-----
The acid of xylose product-----
Peroxidase+++++
Its culture of strains method of the contained microorganism of the present invention is:
1, mother culture media: Carnis Bovis seu Bubali cream 10g, peptone 5g, sucrose 10g, agar 18g, sodium chloride 2.5g, light water 1000ml, pH value 7.5,15P sterilization in 30 minutes.Be cooled to 60 ℃, pour plate.
2, inoculation: strain (CGMCC0601) is inserted in the inoculating loop adhesional wetting line on the flat board, 30 ℃ of constant temperature culture 24 hours, choose single, shape big, milky white, thickness, wire drawing length, neat in edge, mirror are observed the bacterium colony of the unique pattern structure of maintenance down as the production strain.
3, system is female plants: preferred bacterium colony is inserted in the inclined-plane 30 ℃ cultivated three days, Xiang Guanzhong adds sterilized water 3ml, and Mycoderma is washed, and hook goes out culture medium then, inserts the inclined-plane pipe after bacterium liquid is boiled three times, cultivated three days for 30 ℃, and 4 ℃ of preservations, standby.
4, system original seed: culture medium is Carnis Bovis seu Bubali cream 10g, peptone 5g, and sucrose 10g, sodium chloride 2.5g, water steam 200ml, 15P sterilization in 30 minutes.
5, mother is planted connect five bottles of original seeds with one and be as the criterion, plant to mother and add 5.5ml original seed base in the base, the 2ml suction pipe of inhaling ball with band is pressure-vaccum repeatedly, and lawn is washed in the solution, and every milliliter connects one bottle in original seed, mixes back 30 ℃ and cultivates 24 hours, is original seed.
The preparation method of biological preparation of the present invention comprises the following steps:
A, preparation culture medium: culture medium contains Folium Populi Pseudo-simonii powder 25-35 part, Japanese pagodatree leaf powder 20-30 part, Semen Maydis powder 80-120 part, analysis for soybean powder 20-30 part, sodium carbonate 8-10 part, add water to paste, placed 0.5-1 hour, and added water 8000-10000 part, transferring pH value with sodium hydroxide is 8.0-8.5, stir, seal, sterilization in 15P 20-30 minute;
B, culture medium temperature are reduced to 28-32 ℃, by the 5-12% access original seed of culture medium capacity; Cultivated 2-3 days for 30 ± 1 ℃, to white Mycoderma formation;
The phenol of c, adding 0.5-1% stirs, and adds the filter aid of 0.5-1%, filters, and collects limpid transparency liquid.
For guaranteeing that preparation has better therapeutic, wherein the Folium Populi Pseudo-simonii powder is preferably selected lobule Folium Populi Pseudo-simonii powder for use, and the Japanese pagodatree leaf powder is preferably selected Flos Robiniae Pseudoacaciae leaf powder for use.
That the reaction of biological preparation of the present invention and potassium oxalate can generate etc. is big, evenly, disperse, have the spherical particle of light folding endurance, prepared biological preparation contains spherical particle for every milliliter and adds up to 10-20 hundred million, its curative effect is good especially.
Biological preparation of the present invention can be guaranteed its stable curative effect when disease is burnt in treatment by quality control.
Its qualitative checking method is: get this product 5ml and add 10% potassium oxalate 0.2ml mixing and form white emulsion liquid, its precipitation is dissolved in 0.2% dilute sulfuric acid, is insoluble to 36% acetic acid, and dried powder is dissolved in dimethylbenzene.
The reaction of this product and potassium oxalate can generate the water-insoluble solid material, examine under a microscope be wait big, evenly, disperse, have the spherical particle of refractivity, its numbers of particles becomes positive to concern with active ingredient.
Quantitative analysis method is: get this product 5ml, add 10% potassium oxalate 0.2ml, get the 1ml adding distil water after the mixing and be mixed to 100ml, get a little and place on the blood counting chamber, the total number of particles of getting with 400 power microscopes in four medium squares (each medium square has 16 lattices) of four jiaos is calculated.
Formula:
Example: 328 of granule numbers.
Calculate:
The specific granule number that is biological preparation of the present invention is 20.5 hundred million.
The specific granule of biological preparation of the present invention has identical charges, can form homodisperse individuality in solution, can count on blood counting chamber.
Biological preparation of the present invention to the pain of burn wound, ooze out, infect, long-pending dense, the necrosis progrediens of tissue of burn and the cicatrix healing of dark II ° of wound surface, good curative effect is arranged.Use biological preparation of the present invention, can make the scald dry tack free, ooze out minimizing, can accelerate new granulation tissue growth, promote to scald organization healing, have simultaneously that zest is little, pain relieving fast, effective advantages such as control infection, short treating period, preventing from scar.
CGMCC0601 microorganism of the present invention makes the chlorophyll in the culture medium become the red porphyrin of leaf during the fermentation.The carbonyl on the red porphyrin of leaf and the hydroxyl reaction of carboxyl and phenol generate corresponding fat or ether.This is similar to the lipid material that the normal skin surface exists, thereby can play emulsification with the moisture on trauma skin surface and produce the lipid film, can play a protective role to the skin trauma surface.
Excellent results of the present invention has obtained further confirmation by following experimentation.
Pharmacodynamic study:
1, experiment material
1.1 medicine: experimental group, biological preparation of the present invention, lot number 94025; Matched group, the burn spirit, lot number 940766, Le Rentang pharmaceutical factory in Shijiazhuang produces.
1.2 animal: Kunming mouse 24-25g, male and female half and half, effluent north medical college Experimental Animal Center provides.
1.3 strain: staphylococcus aureus (26003), escherichia coli (44102), streptococcus faecalis (32221), bacillus pyocyaneus (10104), Candida albicans (10231) provide by the calibrating of Beijing pharmaceutical biological product.
1.4 culture medium: sabouraud culture medium, plain agar culture medium and meat soup.
2, method and result
2.1 influence to the mice wound tissue healing:
Get healthy mice, the back depilation was used etherization with animal after 24 hours, placed on 80 ℃ of constant temperature aluminium sheets, continued 15 seconds, caused 10% II ° of burn.Burn wound's area is (2 * 3cm approximately
2) (this condition is to determine after trial test is by histopathologic examination).Animal is divided into four groups at random, the blank group, matched group, experimental group is divided into 1 group of experiment, 2 groups of experiments according to high and low two dosage.Every group 12, spray medicine after the scald immediately, blank group water spray, matched group is given clever 0.5ml/ time of burn, experimental group dosage 0.5ml/ time, each is organized 2 times/day, and successive administration 14 days is observed body weight change situation between incrustation time after each treated animal administration, each group of decrustation time and 4 days, 8 days, 12 days.The results are shown in Table 2, table 3.
Table 2: biological preparation of the present invention is to the influence of mice burn wound healing
The group incrustation time (my god) the decrustation time (my god)
Blank group 7.0 ± 1.3 15.6 ± 4.2
Test 1 group of (a large amount) 4.8 ± 0.4
*11.3 ± 2.5
*
Test 2 groups of (low amounts) 4.6 ± 0.8
*11.4 ± 1.3
*
Matched group 5.8 ± 1.1 13.4 ± 3.8
x±s，n＝12，
*P＞0.05
Table 3: biological preparation of the present invention is to the x ± s that influences of mice burn back body weight, and n=12 restrains
Before the group administration after the administration 4 days 8 days 12 days
Blank group 24.4 ± 0.5 22.6 ± 0.6 24.1 ± 0.8 27.2 ± 1.3
Test 1 group of (a large amount) 24.5 ± 0.6 25.8 ± 0.9
*25.7 ± 1.4
*27.2 ± 1.4
Test 2 groups of (low amounts) 24.3 ± 0.3 25.8 ± 0.5
*25.8 ± 0.5
*27.4 ± 0.8
Matched group 24.4 ± 0.4 24.6 ± 0.9 25.2 ± 1.0
*27.4 ± 1.4
*P＞0.05
**P＜0.01
Experiment shows: experimental group can be alleviated the phenomenons such as shouting, jump, tremble that the scald animal causes because of pain, scald wound drying, nothing infect behind the animal continuous use of experimental group, the time that grows the time of crust and take off crust relatively has significant difference all early than matched group with matched group.From experiment, can also observe, after mice is scalded, cause the minimizing of activity and food ration because of severe pain, make weight loss, after the administration, no matter experimental group is a large amount group (biological preparation contains spherical particle for every milliliter and adds up to 2,000,000,000) or low amount group (biological preparation contains spherical particle for every milliliter and adds up to 1,000,000,000), animal ingestion and activity are all very fast to have recovered normal, body weight promptly was significantly improved in administration in 4 days, compared with matched group, had significant difference.
2.2 extracorporeal bacteria inhibitor test:
The bacteriostatic test method is carried out according to Ministry of Public Health " drug inspection method ".
Result of the test sees Table 4.
Table 4: send out of the influence of this open-birth thing preparation to pathogenic bacterium
Golden yellow white
Time (branch) escherichia coli bacillus pyocyaneus contrast
The staphylococcus candidiasis
0 thirty thirty thirty thirty thirty
2 Lv Lv-Lv thirty
4++-Lv thirty
6---+thirty
8---+thirty
10---thirty
Experiment shows that biological preparation of the present invention can produce significant inhibitory effect to 5 kinds of higher pathogenic bacterium of burn wound's infection rate in 10 minutes.
This biological preparation shows through skin medication toxicity test: each treated animal that uses biological preparation of the present invention, at the medication viewing duration, each treated animal feed, drainage and activity are all no abnormal, and breathing and extremity are movable normal, do not have significant change between each group of body weight, do not have dead the generation.
This biological preparation shows through skin medication stimulation test: intact skin and damaged skin group there is no irritant reaction such as erythema and edema.
Its clinical research of biological preparation of the present invention obtains good effect, and clinical research is reported as follows.
Methods of clinical observation and project:
1, observation unit: Hebei Medical College the 3rd hospital, the 256 hospital of the Chinese People's Liberation Army, Shijiazhuang City Changan District hospital, the Shijiazhuang City pendant English biomedical developmental research institute etc. that burns.
2, observation item: the tissue reaction behind exudation, pain relieving, infection, antipruritic, granulation promoting, the termination burn etc.To difference burn factor, degree and consultation time sooner or later, observe its cure time and have or not cicatrix etc.
3, administrated method: I ° burn, wound surface are interrupted sprinkling biological preparation of the present invention to pain and disappear.The wound surface of II ° of burn cleaning, no dirt, the person that do not use other medicines can directly spray this medicine, every day 2-6 time, but if any the emptying of blister low level clip.The pain wound surface every 5 minutes spray medicines once changes positive usual amounts into behind painful the ending.Spray value is not advisable evenly not flow.General 160cm
2Area, consumption liquid 1ml.Dirt being arranged or be covered with other medicines as wound surface should be clean with normal saline flushing earlier, uses the same method then to spray this medicine.Generally take exposure method.The wound surface and the low temperature environment of commute friction can adopt the soak bandaging strapping.Infective wound surface with empyema or necrotic tissue cleaning, is used the soak method, change sprinkling into after wound surface is clean.
Clinical observation:
1, general clinical data: treated fire victim's 787 examples in October, 1993 altogether from 1987 to, and male 388 examples account for 49.3%; Woman's 399 examples account for 50.7%.Minimal ages 8 months, maximum 65 years old age.Burn surface area is 1～37%.II ° of burn 756 examples account for 96.06%, and dark II ° of burn 31 examples account for 3.94%.Wherein treat 3 examples of burning of burning.There are head, face, neck, nose, mouth, ear, shirtfront, back, extremity, buttocks, external genitalia, scrotum etc. in the burn position.
2, fully recovering of therapeutic effect: II ° of burn 84.5% at 5-10 days; 15.6% recovery from illness in 10-15 days, and 3% secondary infection (mostly be and accidentally injure crust) is wherein arranged.Dark II ° of area 10% is with the patient of interior burn, and 80.5% recovery from illness in 15-20 days, and 19.4% recovery from illness in 15-30 days.Can there be the cicatrix healing without skin-grafting yet.
The burn observation of factor, administration time, pain relieving and recovery from illness sees Table 5 to biological preparation of the present invention to difference.
Table 5: biological preparation of the present invention is observed the medication of burn
Pain is ended recovery from illness
The burn burn is caused injury to using burn
% time time remarks
Factor position medicine time example number
(branch) (my god)
Boil liquid extremity, shirtfront
Timely 200 25.4 5-10 2-5 decrustations, no cicatrix
Steam back, face etc.
The same 14～30 minutes 105 13.3 5～15 5～10 is the same
The same 1-7 days 456 57.9 5～15 5～20 is the same
The same with 6 0.8 10～20 15～30 the same more than first half of the month
Red ferrum hands, buttocks timely 2 0.3 5～15 2～9 are the same
Flame front, back 15 minutes 5 0.6 40～45 2～4 are the same
Nitric acid eye, hands detumescence in 10～15 minutes 2 0.3 10～15 2～6 20 minutes
Caustic soda scrotum 3 days 1 0.1 8 takes off thin skin one deck immediately
The same buttocks first quarter moon 1 0.1 is 29 no cicatrixes immediately
Electric arc the back of the hand, 20 minutes-1 day 3 0.6 15 2～4 no cicatrixes of face
Sulphuric acid instep, upper limb 6 minutes-1 day 3 0.6 be 3～6 no cicatrixes immediately
Colophonium hands, sufficient 1-4 days 3 0.6 30 10 no cicatrixes
From observed result as can be seen, pain relieving in 10-20 minute (flame burn pain relieving in 45 minutes) behind burn wound's usefulness biological preparation of the present invention.Recovery from illness is sooner or later relevant with medication, and medication is more early fully recovered soon more.
To II ° of burn, go to a doctor back 30 minutes of burn with interior person, generally can take off thin skin one deck recovery from illness in 5-10 days, leave no trace; Burn has reached 6-48 hour, and wound surface forms blister, and part skin lesion person is arranged, and treats recovery from illness in 5-12 days; Burn has surpassed a week, through other medicines therapeutic effect gastrointestinal disease patient, uses biological preparation treatment of the present invention instead, 40% recovery from illness in 10 days, and 45% recovery from illness in 20 days, 15% (genus residual wound) fully recovered in 30 days, and all do not have scar tissue.
To the treatment that chemical burn, electric arc are hindered, because burn degree and consultation time difference, treatment is generally at recovery from illness in 2-30 days, preventing from scar.
The observation of exudation: burn wound's spraying biological preparation of the present invention is in half an hour, and visible skin lesion wound surface serosity oozes out minimizing, gets rid of the blister of serosity about 1 hour and no longer heaves, and can see red and swollen obvious disappearance of I ° of wound surface in two hours.After the medication, wound surface does not have the intensification phenomenon, shows that biological preparation of the present invention has the effect of anti-tissue reaction.
Biological preparation of the present invention is applicable to: the skin and flesh damage that various chemical factors such as boiled water, the oil that boils, steam, high temp objects, flame, gunpowder, photoelectricity, strong acid, highly basic cause.
The using method of biological preparation of the present invention is:
1, debridement
(1) wound surface infection suppurates not, and do not used any medicine person, as belong to fresh wound surface, can directly use this medicine; As not belonging to fresh wound surface, use this medicine behind the available normal saline flushing.
(2) traumatic infection suppuration person re-uses this medicine after cleaning up with a small amount of 3% hydrogen peroxide earlier.
(3) the wound surface person that uses the other drug after must thoroughly removing, can use this medicine.
2, handle blister
Complete blister adopts the low level clip to get rid of sepage, but will protect the blister skin.Bigger blister can be cut several mouthfuls more, and the sepage pressurization is got rid of, and makes the bubble skin be close to wound surface.The bubble skin of shrinkage or pollution will be wiped out.
3, medication
(1) rubbing method: soak into medicinal liquid with absorbent cotton, softly be applied to equably wound surface, every day 3-4 time.This method is applicable to cleaning, pollution and incrustation face.
(2) spraying: with sprayer unit medicinal liquid is sprayed on wound surface equably, is advisable every day 3-6 time not flow.This method is applicable to the wound surface of cleaning and incrustation.
Embodiment 1:
Preparation lobule Folium Populi Pseudo-simonii powder, Flos Robiniae Pseudoacaciae leaf powder: select the leaves (band petiole) of PopulussimoniiCarr. in 5 to October for use, Flos Robiniae Pseudoacaciae leaf (band petiole) dries, and wears into 40-60 order powder with little steel, and is standby.
Take by weighing PopulussimoniiCarr. powder 3kg, Flos Robiniae Pseudoacaciae leaf powder 2kg, Semen Maydis powder 10kg, analysis for soybean powder 2kg, sodium carbonate 1kg places container, it is an amount of to add water, stir into paste, place half an hour, add water 1000kg, transfer pH value to reach 8.0 with 5N NaOH, under fully stirring, be sub-packed in the glass jar capacity 350ml, insert original seed 35ml, cultivated three days for 30 ℃, white Mycoderma forms, and bacterium liquid is limpid transparent, the thalline long-chain forms spore, count with the specific granule counting method, quantity reaches 2,000,000,000/milliliter, promptly makes the CGMCC0601 fermentation liquid.Pressing 1% of fermentation liquid total amount and add phenol, fully mix, is that radix adds 1% kieselguhr as filter aid with the mixed liquor total amount, stirs 1 minute, with 7
#The canvas normal pressure hangs filter, collects limpid transparency liquid and is finished product.
Embodiment 2:
Preparation Folium Populi Pseudo-simonii powder, Japanese pagodatree leaf powder: select Folium Populi Pseudo-simonii, the Folium sophorae in 5 to October for use, dry, wear into 40-60 order powder with little steel, standby.
Take by weighing Folium Populi Pseudo-simonii powder 2.5kg, Japanese pagodatree leaf powder 3kg, Semen Maydis powder 8kg, analysis for soybean powder 3kg, sodium carbonate 1kg, place container, it is an amount of to add water, stir into paste, place half an hour, add water 800kg, transfer pH value to reach 8.0 with 5N NaOH, under fully stirring, be sub-packed in the glass jar, capacity 350ml inserts original seed 30ml, cultivates three days for 30 ℃, the white Mycoderma forms, bacterium liquid is limpid transparent, and the thalline long-chain forms spore, counts with the specific granule counting method, quantity reaches 1,500,000,000/milliliter, promptly makes the CGMCC0601 fermentation liquid.Pressing 0.5% of fermentation liquid total amount and add phenol, fully mix, is that radix adds 1% kieselguhr as filter aid with the mixed liquor total amount, stirs 1 minute, with 7
#The canvas normal pressure hangs filter, collects limpid transparency liquid and is finished product.
Claims (7)
1, a kind of biological preparation that is used for the treatment of burn is characterized in that it contains Bacillus cercus CGMCC0601 fermentation liquid.
2, the biological preparation that is used for the treatment of burn according to claim 1 is characterized in that being added with in the said fermentation liquid phenol of 0.5-1.0%.
3, the biological preparation that is used for the treatment of burn according to claim 1, it is characterized in that the reaction of said biological preparation and potassium oxalate generate etc. big, evenly, disperse, have the spherical particle of refractivity.
4, the biological preparation that is used for the treatment of burn according to claim 3 is characterized in that every milliliter of described biological preparation contains spherical particle and adds up to 10-20 hundred million.
5, a kind of preparation method that is used for the treatment of the biological preparation of burn according to claim 2 is characterized in that it includes the following step:
A, preparation culture medium: culture medium contains Folium Populi Pseudo-simonii powder 25-35 part, Japanese pagodatree leaf powder 20-30 part, Semen Maydis powder 80-120 part, analysis for soybean powder 20-30 part, sodium carbonate 8-10 part, add water to paste, placed 0.5-1 hour, and added water 8000--10000 part, transferring pH value with sodium hydroxide is 8.0-8.5, stir, seal, sterilization in 15P 20-30 minute;
B, culture medium temperature are reduced to 28-32 ℃, by the 5-12% access CGMCC0601 strain of culture medium capacity; Cultivated 2-3 days for 30 ± 1 ℃, to white Mycoderma formation;
The phenol of c, adding 0.5-1% stirs, and adds the filter aid of 0.5--1%, filters, and collects limpid transparency liquid.
6, the preparation method that is used for the treatment of the biological preparation of burn according to claim 5 is characterized in that said Folium Populi Pseudo-simonii powder is a lobule Folium Populi Pseudo-simonii powder.
7, the preparation method that is used for the treatment of the biological preparation of burn according to claim 5 is characterized in that said Japanese pagodatree leaf powder is a Flos Robiniae Pseudoacaciae leaf powder.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB011235837A CN1164278C (en) | 2001-08-03 | 2001-08-03 | Biological preparation for treating burn and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB011235837A CN1164278C (en) | 2001-08-03 | 2001-08-03 | Biological preparation for treating burn and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1399971A true CN1399971A (en) | 2003-03-05 |
| CN1164278C CN1164278C (en) | 2004-09-01 |
Family
ID=4665174
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB011235837A Expired - Fee Related CN1164278C (en) | 2001-08-03 | 2001-08-03 | Biological preparation for treating burn and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1164278C (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107468715A (en) * | 2017-10-12 | 2017-12-15 | 卢筱桂 | Bacillus cercus CGMCC0601 zymotic fluids are preparing the application in treating diabetes trauma Wound medicine |
| CN111821253A (en) * | 2020-08-11 | 2020-10-27 | 卢筱桂 | Chlorophyll spray bacteriostatic liquid formula for diabetic gangrene and extraction process thereof |
| CN113350487A (en) * | 2020-03-05 | 2021-09-07 | 祝康生物科技有限公司 | Antiviral composition and preparation method and application thereof |
-
2001
- 2001-08-03 CN CNB011235837A patent/CN1164278C/en not_active Expired - Fee Related
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107468715A (en) * | 2017-10-12 | 2017-12-15 | 卢筱桂 | Bacillus cercus CGMCC0601 zymotic fluids are preparing the application in treating diabetes trauma Wound medicine |
| CN113350487A (en) * | 2020-03-05 | 2021-09-07 | 祝康生物科技有限公司 | Antiviral composition and preparation method and application thereof |
| CN111821253A (en) * | 2020-08-11 | 2020-10-27 | 卢筱桂 | Chlorophyll spray bacteriostatic liquid formula for diabetic gangrene and extraction process thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1164278C (en) | 2004-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1113599C (en) | Antimicrobial treatment for herpes simplex virus and other infectious diseases | |
| CN100340295C (en) | Oral administered compound colloid pectin bismuth preparation and its preparing process | |
| CN100556292C (en) | Plant source antimicrobials for raising and its production and application | |
| CN111234007A (en) | Collagen active peptide for promoting wound healing | |
| CN101543658B (en) | Cervical cap for preventing and treating cervical erosion and preparation method thereof | |
| CN1895683A (en) | Nanometer-silver antibacterial coating, its preparation and use | |
| CN102671011B (en) | Traditional Chinese medicine compound powder for preventing and treating yellow and white scour of piglets and preparation method thereof | |
| CN1965650A (en) | Multiple metal ion chelated green antibacterial agent of chitosan | |
| CN1164278C (en) | Biological preparation for treating burn and preparation method thereof | |
| WO2005012503A1 (en) | Novel lactobacillus, living body activating lactobacillus preparation and preventive or therapeutic agent against living body infection | |
| CN1484959A (en) | Sterilization formulation and wet tissue, preparation method and use | |
| CN1765369A (en) | Nano silver gel and its use | |
| CN101475920B (en) | Preparation method of Bacillus pumilus for treating burn and metabolite | |
| CN1132517C (en) | Compound lysostaphin enzyme disinfectant | |
| CN101269164B (en) | Method of preparing virus bacterium blood serum Chinese aloe vaccine powder preparation and oral liquid for livestock, poultry biology and aquatic animal | |
| CN107595819A (en) | A kind of Nano diamond modified liquid adhesive bandage and preparation method thereof | |
| CN101053657A (en) | External applied preparations for treating intractable skin ulcer | |
| CN1177637A (en) | Preparation of living bacillus subtilis and preparation method thereof | |
| CN111480614A (en) | Ostrich parasite control method | |
| CN111991384A (en) | Protocatechuic acid and application of compound protocatechuic acid thereof in improving performance of livestock and poultry | |
| CN1239169C (en) | Externally applied medicinal composition for resisting inflammation and repressing and killing bacteria and preparing method | |
| CN1857675A (en) | Zedoary oil eye drop and its preparing method | |
| CN113367099B (en) | Cultivation method and application of coccidiosis-free experimental pigeon | |
| CN1259080C (en) | Bacteria and virus resisting and inflammation eliminating eye drop and its preparing process | |
| CN109620877A (en) | Pure Chinese medicine fowl antibacterium disease preparation and preparation method thereof and application method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20040901 Termination date: 20200803 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |